1. Home
  2. CFFN vs NKTR Comparison

CFFN vs NKTR Comparison

Compare CFFN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

N/A

Current Price

$8.45

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

N/A

Current Price

$37.46

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CFFN
NKTR
Founded
1893
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
CFFN
NKTR
Price
$8.45
$37.46
Analyst Decision
Buy
Buy
Analyst Count
3
15
Target Price
$9.50
★ $133.08
AVG Volume (30 Days)
★ 1.1M
747.0K
Earning Date
10-28-2026
11-12-2026
Dividend Yield
★ 4.00%
N/A
EPS Growth
★ 79.31
N/A
EPS
★ 0.51
N/A
Revenue
$16,300,000.00
★ $307,711,000.00
Revenue This Year
$7.98
N/A
Revenue Next Year
$4.98
$27.72
P/E Ratio
$17.22
★ N/A
Revenue Growth
6.54
★ 86.00
52 Week Low
$6.07
$33.40
52 Week High
$9.26
$109.00

Technical Indicators

Market Signals
Indicator
CFFN
NKTR
Relative Strength Index (RSI) 49.29 37.37
Support Level $8.43 $35.61
Resistance Level $8.83 $39.89
Average True Range (ATR) 0.21 1.66
MACD 0.03 0.96
Stochastic Oscillator 47.21 36.06

Price Performance

Historical Comparison
CFFN
NKTR

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: